Engineer Commissioning & Qualification
Bavarian Nordic
Engineer Commissioning & Qualification
Bavarian Nordic
Develops cancer immunotherapies and vaccines
About the role:
As an Engineer Commissioning & Qualification, you will play an important role in ensuring that equipment, utilities and computerized systems across our Thörishaus site are commissioned, qualified and validated in a compliant and robust way. Working closely with cross-functional teams and external partners, you will act as a primary technical point of contact for C&Q topics and help ensure that our systems meet GMP and regulatory requirements from day one.
Your responsibilities:
About you:
What we offer
Ready to join us?
If this sounds like your next career step, click “APPLY” to go to our application form. We interview on an ongoing basis, so we encourage you to apply early.
Applications submitted by email cannot be considered.
We kindly ask recruitment agencies not to contact us about this position.
Bavarian Nordic is a global vaccine company with a mission to improve health and save lives through innovative vaccines. We are a preferred supplier of mpox and smallpox vaccines to governments to enhance public health preparedness and have a leading portfolio of travel vaccines. We are headquartered in Denmark and have manufacturing, research, and sales offices across Europe and North America.
Bavarian Nordic is an Equal Opportunity Employer. All qualified applications will receive consideration for employment and will not be discriminated against based on race, color, sex, sexual orientation, gender identity, national origin, disability, or protected veteran status.
For more information, visit www.bavarian-nordic.com
#LI-PP1
Develops cancer immunotherapies and vaccines
Bavarian Nordic develops, manufactures, and sells vaccines and cancer immunotherapies. Its vaccines and immunotherapies aim to train the body's immune system to recognize and attack cancer cells or infectious agents. The company operates as a fully integrated biotechnology business, handling development, production, and commercialization, and it collaborates with partners and licensing agreements to bring its products to market. A key differentiator is its track record, including European marketing authorization for an Ebola vaccine and a licensing deal for a COVID-19 vaccine, plus ongoing partnerships. The company's goal is to improve global health by reducing the risk of infectious diseases and by improving cancer treatment outcomes.
Explore more opportunities at Bavarian Nordic